Company: NIVFW
Filing Date: 2025-05-29
Form Type: F-1/A
Source: 0001213900-25-048554
Chunk: 83

Company: NewGenIvf Group Ltd
Filing Date: 2025-05-29
Form: F-1/A
Chunk 83
---
-compliance of regulatory requirements by NewGenIvf’s investees may cause substantial harm to NewGenIvf’s reputations and the value of NewGenIvf’s investment. In addition, if the resulting business from such a transaction fails to meet NewGenIvf’s expectations, or it fails to successfully integrate such businesses into its own, its business, financial condition and results of operations may be adversely affected or it may be exposed to unknown risks or liabilities. If NewGenIvf is unable to effectively address these challenges, its ability to execute acquisitions as a component of its long-term strategy will be impaired, which could have an adverse effect on its growth. As a result of the above, NewGenIvf’s strategies may not be successfully implemented beyond the current markets. Any investment might not achieve the synergies, operational or financial benefits it expects and may adversely impact NewGenIvf’s operating results. In addition, NewGenIvf cannot assure you that any future investment in or acquisition of new businesses or technology will lead to the successful development of new or enhanced products and services or that any new or enhanced products and services, if developed, will achieve market acceptance, or prove to be profitable. 50 Changes in NewGenIvf’s effective tax rate or tax liability may have an adverse effect on its results of operations. NewGenIvf’s effective tax rate could increase due to several factors, including, but not limited to:

| ● | changes in the relative amounts of income before taxes in the various              
 jurisdictions in which NewGenIvf operates that have differing statutory tax rates; |

| ● | changes in tax laws, tax treaties, and regulations or the interpretation 
 of them;                                                                 |

| ● | changes to its assessment about its ability to realize its deferred                                                                 
 tax assets that are based on estimates of its future results, the prudence and feasibility of possible tax planning strategies, and 
 the economic and political environments in which NewGenIvf does business;                                                           |

| ● | the outcome of future tax audits, examinations, or administrative appeals; 
 and                                                                        |

| ● | limitations or adverse findings regarding its ability to do business 
 in some jurisdictions.                                               |

Any of these developments could have an adverse effect on its results of operations. NewGenIvf’s reported financial results may be adversely affected by changes in accounting principles generally accepted in the U.S. A change in the U.S. accounting principles could have a significant effect on NewGenIvf’s reported results of operations and could affect the reporting of transactions already